Is Hunan Jiudian Pharmaceutical Co., Ltd.'s (SZSE:300705) Latest Stock Performance Being Led By Its Strong Fundamentals?

Simply Wall StJul 17 18:57 ET

Hunan Jiudian Pharmaceutical's (SZSE:300705) Five-year Earnings Growth Trails the 37% YoY Shareholder Returns

Simply Wall StJun 26 19:22 ET

Is Hunan Jiudian Pharmaceutical Co., Ltd. (SZSE:300705) Trading At A 41% Discount?

Simply Wall StJun 10 03:50 ET

Jiudian Pharmaceutical (300705.SZ): Ifluprofen patch approved for clinical trials

Gelonghui, May 22丨Jiudian Pharmaceutical (300705.SZ) announced that the company recently received the “Drug Clinical Trial Approval Notice” issued by the State Drug Administration. The ifluprofen patch was approved to carry out clinical trials for osteoarthritis pain relief, and clinical trial research will be carried out after completing relevant preparations.

Gelonghui FinanceMay 22 05:29 ET

Ping An Securities: The terminal market resumes growth and selects varieties based on space and pattern

Ping An Securities released a research report saying that judging from changes in the scale and pattern of terminal drug use, the industry ushered in restorative growth in the post-pandemic era. Innovative drugs and varieties with high barriers and good patterns are growing faster than the overall growth rate.

Zhitong FinanceMay 21 22:21 ET

Jiudian Pharmaceutical (300705.SZ): Jiao Qi Musk Gel Patch completed the declared production in December 2023 and is expected to be approved in 2025

Gelonghui, May 21丨Jiudian Pharmaceutical (300705.SZ) recently received a survey on “Expected marketing time and promotion plan for the traditional Chinese medicine gel paste pepper Qimusk?” The company replied that the production of Jiaoqi Musk Gel Patch has been declared for production in December 2023 and is expected to be approved in 2025. The sales channels for this product are still mainly in-hospital channels. The focus is on supporting hospital development, hoping to set it as a benchmark for new traditional Chinese medicine pastes.

Gelonghui FinanceMay 21 05:30 ET